[1] 张 政,王杏飞,戴 辉. 细胞毒性药物不合理用药浅析[J]. 中国药业,2010,19(17):55-55.
[2] 王宗凯,刘 煜. 抗体偶联药物的有关进展[J]. 药物生物技术,2011,18(4):359-363.
[3] Fang J,Nakamura H,Maeda H. The EPR effect:Unique features of tumor blood vessels for drug delivery,factors involved,and limitations and augmentation of the effect[J]. Adv Drug Deliver Rev,2011 63(3):136-151.
[4] 杨 眉,李 钰,徐冬燕,等. 靶向型药物载体在抗肿瘤治疗中的研究进展[J]. 材料导报A,2014,28(2):60-61.
[5] Dosio F,Stella B,Arpicco S,et al. Macromolecules as taxane delivery systems[J]. Expert Opin Drug Del,2011,8(1):33-55.
[6] Wang Y,Yang X,Yang J,et al. Self-assembled nanoparticles of methotrexate conjugated O-carboxymethyl chitosan:Preparation characterization and drug release behavior in vitro[J]. Carbohyd Polym 2011,86(4):1665-1670.
[7] Luo Q,Wang P,Miao Y,et al. A novel 5-fluorouracil prodrug using hydroxyethyl starch as a macromolecular carrier for sustained release[J]. Carbohyd Polym,2012,87(4):2642-2647.
[8] 刘珍宝,石依倩,陈长仁,等. 核酸适配体在肿瘤靶向治疗中应用的研究进展[J]. 科学通报,2014,9:1267-1279.
[9] Bassi P,Volpe A,D'agostino D,et al. Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guerin refractory carcinoma in situ of the bladder:Results of a phase I study[J]. J Urology,2011 185(2):445-449.
[10] 袁玉姣,蒋 革,董 爽. 透明质酸衍生物在生物药品传递方面的研究进展[J]. 沈阳药科大学学报,2013,30(3):222-223.
[11] Danhauser-Riedl S,Hausmann E,Schick HD,et al. Phase I clinical and pharmacokinetic trial of dextran conjugated doxorubicin (AD-70,DOX-OXD)[J]. Invest New Drug,1993,11(2):187-195.
[12] 梁艳超,张 娜. 聚合物治疗体系的设计和应用[J]. 中国新药与临床杂志,2014,33(11):778-780.
[13] 王鲁霞,吴延立,马文平. 壳寡糖的制备方法及其在食品中的应用现状[J]. 安徽农业科学,2014,42(32):11485-11487.
[14] 生举正,凌沛学,王凤山. 透明质酸生物合成的研究进展[J]. 中国生化药物杂志,2009,30(2):135-137.
[15] Luo XM,Chen MH,Zhang Y,et al. Pharmacokinetics and antitumor efficacy of micelles assembled from multiarmed amphiphilic copolymers with drug conjugates in comparison with drug-encapsulated micelles[J]. Eur J Pharm Biopharm,2016,98:9-19.
[16] Xu Z,Zheng W,Yin Z. Synthesis and optimization of a bifunctional hyaluronan-based camptothecin prodrug[J]. Arch Pharm,2014,347: 240-246.
[17] Wang Y,Liu YY,Liu Y,et al. A polymeric prodrug of cisplatin based on pullulan for the targeted therapy against hepatocellular carcinoma[J]. Int J Pharm,2015,483(1/2):89-100.
[18] Hou L,Fan Y,Yao J,et al. Low molecular weight heparin-all-trans-retinoid acid conjugate as a drug carrier for combination cancer chemotherapy of paclitaxel and all-trans-retinoid acid[J]. Carbohyd Polym,2011,86(3):1157-1166.
[19] Homma A,Sato H,Tamura T,et al. Synthesis and optimization of hyaluronic acid-methotrexate conjugates to maximize benefit in the treatment of osteoarthritis[J]. Bioorgan Med Chem,2010,18(3): 1062-1075.
[20] Luo Y,Bernshaw NJ,Lu ZR,et al. Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates[J]. Pharm Res-Doror,2002,19(4):396-402.
[21] Cai S,Thati S,Bagby TR,et al. Localized doxorubicin chemotherapy with a biopolymeric nanocarrier improves survival and reduces toxicity in xenografts of human breast cancer[J]. J Control Release,2010 146(2):212-218.
[22] Ringsdorf H. Structure and properties of pharmacologically active polymers[J]. J Polym Sci Pol Chem,1975,51(1):135-153.
[23] 陈建树,王婧茜,易 喻,等. 透明质酸及其衍生物研究进展[J]. 中国生物工程杂志,2015,35(2):111-118.
[24] 王颖智,刘鷖雯,何怡青,等. 实时荧光定量PCR检测CD44和RHAMM在胃肠肿瘤中的表达[J]. 检验医学,2008,23(2):338-342.
[25] Ouasti S,Kingham PJ,Terenghi G,et al. The CD44/integrins interplay and the significance of receptor binding and representation in the uptake of RGD-functionalized hyaluronic acid[J]. Biomaterials 2012,33:1120-1134.
[26] 徐 新,陆明秋,叶玟希,等. 己二酸二酰肼交联透明质酸薄膜的制备及性能研究[J]. 广东化工,2012,39(2):47-47.
[27] Oh EJ,Park K,Kim KS,et al. Target specific and long-acting delivery of protein,peptide,and nucleotide therapeutics using hyaluronic acid derivatives[J]. J Control Release,2010,141(1):2-12.
[28] Galer CE,Sano D,Ghosh SC,et al. Hyaluronic acidpaclitaxel conjugate inhibits growth of human squamous cell carcinomas of the head and neck via a hyaluronic acidmediated mechanism[J]. Oral Oncol 2011,47:1039-1047.
[29] 邱立朋,龙苗苗,陈大为. 透明质酸肿瘤靶向给药系统的研究进展[J]. 药学学报,2013,48(9):1376-1382.
[30] Nagahama K,Sano Y,Kumano T. Anticancer drug-based multi-functional nanogels through self-assembly of dextran-curcumin conjugates toward cancer theranostics[J]. Bioorg Med Chem Lett 2015,5:2519-2522.
[31] 杨梅竹,薛亚楠,蔡 宁,等. 葡聚糖的环氧化修饰与表征[J]. 化学与生物工程,2013,30(2):43-45.
[32] Young J,Do HK,Chung WC,et al. Doxorubicin-incorporated polymeric micelles composed of dextran-b-poly (DL-lactide-co-glycolide) copolymer[J]. Int J Nanomed,2011,6:1415-1427.
[33] 闫雪霏,杨 晔,尹登科. 两亲性多糖自组装胶束给药系统研究进展[J]. 中国生化药物杂志,2014,34(4):175-177.
[34] Soepenberg O,de Jonge MJ,Sparreboom A,et al. Phase I and pharmacokinetic study of DE-310 in patients with advanced solid tumors[J]. Clin Cancer Res,2005,11(2):703-711.
[35] Bao XL,Wang W,Wang C,et al. A chitosan-graft-PEI-candesartan conjugate for targeted co-delivery of drug and gene in anti-angiogenesis cancer therapy[J]. Biomaterials,2014,35:1-17.
[36] 孙 川,梁云星,郑 颖,王 宁,梁桂贤. 受体介导的主动靶向壳聚糖衍生物递药载体的研究进展[J]. 中国新药杂志,2015 24(22):2584-2587.
[37] Upadhyaya L,Singh J,Agarwal,et al. The implications of recent advances in carboxymethyl chitosan based targeted drug delivery and tissue engineering applications[J]. Carbohyd Polym,2015,117:524-536.
[38] Talaei F,Azhdarzadeh M,Hshemi Nasel H,et al. Core shell methyl methacrylate chitosan nanoparticles:In vitro mucoadhesion and complement activation. DARU[J]. J Pharm Sci-Us,2011,19(4):257-265.
[39] 李 庆. 靶向乳腺癌的多西他赛壳聚糖纳米粒抑瘤作用研究[J]. 中国现代医学杂志,2015,25(3):17-22.
[40] 罗华丽,闫乃鹤. 壳聚糖在靶向制剂中的研究进展[J]. 湖北农业科学,2013,10(19):4582-4585.
[41] Lee E,Lee J,Lee IH,et al. Conjugated chitosan as a novel platform for oral delivery of paclitaxe[J]. J Med Chem,2008,51(20):6442-6449.
[42] Park K,Kim YS,Lee GY,et al. Tumor endothelial cell targeted cyclic RGD-modified heparin derivative:Inhibition of angiogenesis and tumor growth[J]. Pharm Res-Dordr,2008,25(12):2786-2798.
[43] Sugahara S,Kajiki M,Kuriyama H,Kobayashi T. Carrier effects on antitumor activity and neurotoxicity of AZ10992,a paclitaxel-carboxymethyl dextran conjugate,in a mouse model[J]. Bio Pharm Bull,2008,31(2):223-230.
[44] Cremers HFM,Feijen J,Kwon G,et al. Albumin-heparin microspheres as carriers for cytostatic agents[J]. J Control Release,1990 11(1/2/3):167-179.
[45] 孙 川,邢 洋,胡华颖,等. 低分子肝素pH敏感巯基壳聚糖纳米粒的制备及体外黏膜透过性评价[J]. 中国药学杂志,2014 49(16):1414-1416.
[46] Li L,Kim JK,Huh KM,et al. Targeted delivery of paclitaxel using folate-conjugated heparin-poly(β-benzyl-L-aspartate) self-assembled nanoparticles[J]. Carbohyd Polym,2012,87(3):2120-2128.
[47] 李 宁,刘晓燕. 聚合物-药物结合物递药系统的研究进展[J]. 药物生物技术,2015,22(4):357-361.
[48] Gaur S,Wang YF,Chen LL,et al. Pharmacodynamic and pharmacogenomic study of the nanoparticle conjugate of camptothecin CRLX101 for the treatment of cancer[J]. Nanomed-Nanotechnol 2014,10(7):1477-1486.
[49] Davis ME. Design and development of IT-101,a cyclodextrin-containing polymer conjugate of camptothecin[J]. Adv Drug Deliver Rev,2009,61(13):1189-1192.
[50] Alcarol S,Ventura CA,Paolino D,et al. Preparation characterization,molecular modeling and in vitro activity of paclitaxel-cyclodextrin complexes[J]. Bioorg Med Chem Lett,2002,12:1637-1641.
[51] 李 进,邵大钊,张钊华,等. 萜类化合物与环糊精包合物的研究进展[J]. 云南师范大学学报,2014,34(6):19-22. |
